Fuji Pharma Invests US$50 Million in Alvotech to Boost Biosimilar Business in Japan

December 21, 2018
Fuji Pharma has entered into an agreement with Luxemburg-based Alvotech Holdings to acquire a 4.2% stake in the biopharma for US$50 million. Earlier in November, the Japanese company closed an exclusive partnership deal with Alvotech Holdings’ Iceland subsidiary for the...read more